Defendant Name: Stryker Corporation

Defendant Type: Public Company
SIC Code: 3841
CUSIP: 86366710

Document Reference: 34-84308

Document Details

Legal Case Name In the Matter of Stryker Corporation
Document Name Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order
Document Date 28-Sep-2018
Document Format Administrative Proceeding
File Number 3-18853
AAER 3990
Allegation Type Foreign Corrupt Practices Act
Document Summary The Commission stated: "This matter concerns violations of the books and records and internal accounting controls provisions of the Exchange Act by Stryker, a global leader in the medical technology industry, related to its operations in India, China, and Kuwait."

Disgorgement & Penalty Information

Resolutions
Cease and Desist Order
Compliance Related Independent Consultant
Cooperation Before the Resolution
Remedial Acts or Efforts Before the Resolution
Monetary Penalties:

Civil Penalty

Individual:     $7,800,000.00 Shared:    

Related Documents:

2018-222 28-Sep-2018 Press Release--Administrative Proceeding
SEC Charges Stryker A Second Time for FCPA Violations
The Commission stated: "The Securities and Exchange Commission today charged Stryker Corp. with violating the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA), the second time the SEC has brought an FCPA action against the Michigan-based medical device company."